[HTML][HTML] SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus

MI Andersson, CV Arancibia-Carcamo… - Wellcome open …, 2020 - ncbi.nlm.nih.gov
Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses
PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been …

[HTML][HTML] SARS-CoV-2 viremia is associated with COVID-19 severity and predicts clinical outcomes.

JL Jacobs, W Bain, A Naqvi, B Staines, P Castanha… - 2021 - dukespace.lib.duke.edu
Background SARS-CoV-2 viral RNA (vRNA) is detected in the bloodstream of some patients
with COVID-19 (" RNAemia") but it is not clear whether this RNAemia reflects viremia (ie …

Severe acute respiratory syndrome coronavirus 2 viremia is associated with coronavirus disease 2019 severity and predicts clinical outcomes

JL Jacobs, W Bain, A Naqvi, B Staines… - Clinical Infectious …, 2022 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA
(vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 …

High frequency of SARS-CoV-2 RNAemia and association with severe disease

CA Hogan, BA Stevens, MK Sahoo… - Clinical Infectious …, 2021 - academic.oup.com
Background Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
RNA in blood, also known as RNAemia, has been reported, but its prognostic implications …

Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review

TL Dao, VT Hoang, P Gautret - European Journal of Clinical Microbiology …, 2021 - Springer
Many studies have shown that re-positive tests for SARS-CoV-2 by RT-PCR in recovered
COVID-19 patients are very common. We aim to conduct this review to summarize the …

First 12 patients with coronavirus disease 2019 (COVID-19) in the United States

COVID-19 Investigation Team, SA Kujawski, KK Wong… - MedRxiv, 2020 - medrxiv.org
Introduction More than 93,000 cases of coronavirus disease (COVID-19) have been
reported worldwide. We describe the epidemiology, clinical course, and virologic …

[PDF][PDF] SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: a retrospective cohort study

K Hagman, M Hedenstierna, P Gille-Johnson… - Clin Infect …, 2020 - scienceopen.com
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. This is an Open Access article …

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19

F Tejerina, P Catalan, C Rodriguez-Grande… - BMC infectious …, 2022 - Springer
Background There is a paucity of knowledge on the long-term outcome in patients
diagnosed with COVID-19. We describe a cohort of patients with a constellation of symptoms …

Evaluation of SARS-CoV-2 viral RNA in fecal samples

A Mesoraca, K Margiotti, A Viola, A Cima, D Sparacino… - Virology journal, 2020 - Springer
The need for timely establishment of a complete diagnostic protocol of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 …

SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens

L Peng, J Liu, W Xu, Q Luo, D Chen… - Journal of medical …, 2020 - Wiley Online Library
Purpose The purpose of this study was to detect severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) ribonucleic acid (RNA) in urine and blood specimens, and …